| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 07/17/2013 | CN101861171B Polysaccharides grafted by polyamine for preparing radioactive pharmaceutical composition |
| 07/17/2013 | CN101675997B Prosthetic groups useful in the synthesis of radiopharmaceutical compounds |
| 07/16/2013 | US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/16/2013 | US8486409 Alpha-emitting constructs and uses thereof |
| 07/16/2013 | US8486391 Cancer treatment kits using antibodies to aminophospholipids |
| 07/16/2013 | US8486370 Heterocyclic ligands for integrin imaging and therapy |
| 07/16/2013 | CA2493888C Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications |
| 07/11/2013 | US20130177647 Methods for manipulating satiety |
| 07/11/2013 | US20130177501 In vivo imaging method of mood disorders |
| 07/11/2013 | DE102008047781B4 Peptide, die an durch Matrix-Metalloprotease 2 modifiziertes humanes Kollagen IV binden, pharmazeutische Zubereitung und deren Verwendung Peptides that bind to modified by matrix metalloprotease 2 human collagen IV, pharmaceutical preparation and the use thereof |
| 07/10/2013 | CN103197067A Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 07/10/2013 | CN103193867A 18F-RGD polypeptide and application thereof as PET imaging agent |
| 07/10/2013 | CN103191447A RGD (Arg-Gly-Asp)-like peptide PET (positron emission tomography) developing agent of targeting integrin alpha v beta 3, as well as preparation method and application thereof |
| 07/10/2013 | CN102552949B 99mTc-labeled RGD (Arginine-Glycine-Aspartic acid) polypeptide tumor diagnosis medicament and preparation method thereof |
| 07/10/2013 | CN102100918B Evaluation method for disintegration dynamics process in plant shell vacant capsule |
| 07/10/2013 | CN101180400B Nanoparticles comprising RNA ligands |
| 07/09/2013 | USRE44354 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 07/09/2013 | US8481478 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 07/09/2013 | US8481003 Anti-CD74 immunoconjugates and methods |
| 07/09/2013 | US8481002 Method of preparation of uranium nitride |
| 07/09/2013 | US8481000 Thickened beverages for dysphagia |
| 07/09/2013 | CA2570687C Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes and methods for positron emission imaging with radiolabeled halogenated xanthene diagnostic agents |
| 07/04/2013 | WO2013014538A3 Single-domain antibodies and graphene coated magnetic metal nanoparticles conjugate and methods for using the same |
| 07/04/2013 | US20130171069 Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof |
| 07/04/2013 | US20130171066 Polymeric complements to a b-amyloid peptides |
| 07/04/2013 | US20130171064 Anti-CD74 Immunoconjugates and Methods of Use |
| 07/04/2013 | US20130171062 Mapping in vivo eosinophil activation in eosinophilic esophagitis |
| 07/04/2013 | US20130171061 Anti-human transferrin receptor antibody and uses thereof |
| 07/03/2013 | EP2610234A1 Catalytic radiofluorination |
| 07/03/2013 | EP2609936A1 Method for making rhenium-186/188 labeled human serum albumin microspheres and kit for making the same and method for using the kit |
| 07/03/2013 | EP2609934A1 Receptor And Antigen Targeted Prodrug |
| 07/03/2013 | EP2609932A2 Variant target binding agents and uses thereof |
| 07/03/2013 | CN102617728B Preparation process of 18F labeled product of Exendin-4 |
| 07/03/2013 | CN102336908B <99m>Tc complex, and preparation method, intermediate and application thereof |
| 07/02/2013 | USRE44338 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 07/02/2013 | US8475765 Hydroxyalkyl starch derivatives |
| 07/02/2013 | US8475764 Labelled adrenomedullin derivatives and their use for imaging and therapy |
| 07/02/2013 | US8475763 Method of determining the course of treatment for a patient having adenocarcinoma |
| 06/27/2013 | WO2013096776A2 Radioactive compositions and methods for their therapeutic use |
| 06/27/2013 | WO2013096388A1 Telodendrimers with enhanced drug delivery |
| 06/27/2013 | WO2013095273A1 Contrast agent for imagining myocardial perfusion |
| 06/27/2013 | WO2013093099A1 Stabilization of peptidic radiopharmaceuticals using uric acid or derivatives thereof |
| 06/27/2013 | WO2013093025A1 18f - fluciclovine compositions in citrate buffers |
| 06/27/2013 | WO2013092742A1 Method for patient selection |
| 06/27/2013 | WO2013061083A3 Therapeutic agents and uses thereof |
| 06/27/2013 | US20130165631 Bisaminoethanethiol-targeting ligand conjugates and compositions |
| 06/27/2013 | US20130164218 Hypoxia inducible factor-1 pathway inhibitors and uses as anticancer and imaging agents |
| 06/27/2013 | US20130164216 Bladder cancer tumor marker, antibody and use thereof |
| 06/27/2013 | US20130164214 Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells |
| 06/27/2013 | CA2853415A1 18f - fluciclovine compositions in citrate buffers |
| 06/26/2013 | EP2606911A1 Receptor And Antigen Targeted Prodrug |
| 06/26/2013 | EP2606056A2 High-valent palladium fluoride complexes and uses thereof |
| 06/26/2013 | EP2605802A1 Peptide radiotracer compositions |
| 06/26/2013 | EP2605801A1 Imaging tuberculosis with pyrazinamide contrast agents |
| 06/26/2013 | EP2605800A1 Process for producing radiohalogenated bioconjugates and products thereof |
| 06/26/2013 | CN103179991A In vivo imaging method for cancer |
| 06/26/2013 | CN103169981A Method for eliminating and reducing generation of accelerated blood clearance phenomenon |
| 06/25/2013 | US8470822 Folate mimetics and folate-receptor binding conjugates thereof |
| 06/25/2013 | US8470782 Transglutaminase inhibitors and methods of use thereof |
| 06/25/2013 | US8470528 Methods and compositions related to adenoassociated virus-phage particles |
| 06/25/2013 | US8470297 FDG-pet evaluation of Ewing's sarcoma sensitivity |
| 06/25/2013 | US8470296 Injectable chemotherapeutic solution of Erythrosin B, Phloxine B, Rose Bengal, 4,5,6,7-Tetrabromoerythrosin or their salts in a hydrophilic vehicle containing sodium, potassium, calcium or magnesium chloride, phosphate, or nitrate; low levels of pyrogens and particles |
| 06/25/2013 | US8470295 Methods of treatment of androgenic steroidal hormone dependent cancer with auger electron-emitting nucleoside analogs |
| 06/25/2013 | US8470294 Flexible and/or elastic brachytherapy seed or strand |
| 06/25/2013 | US8469943 Coated implantable medical device |
| 06/20/2013 | WO2013088395A1 Clicked somatostatin conjugated analogs for biological applications |
| 06/20/2013 | WO2013088363A1 Chimeric therapeutic anti - cd37 antibodie hh1 |
| 06/20/2013 | US20130156701 Method of preparing ethacrynic amide derivatives and application thereof |
| 06/20/2013 | US20130156699 Radiolabeled compounds and uses thereof |
| 06/20/2013 | US20130156698 Tissue targeting |
| 06/20/2013 | US20130156691 Antibody Therapy |
| 06/19/2013 | EP2605019A2 Sentinel lymph node marker capable of multi-mode imaging |
| 06/19/2013 | EP2604290A2 Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents |
| 06/19/2013 | EP2604284A1 Receptor And Antigen Targeted Prodrug |
| 06/19/2013 | EP2604283A1 Receptor And Antigen Targeted Prodrug |
| 06/19/2013 | EP2604281A1 Clicked somatostatin conjugated analogs for biological applications |
| 06/19/2013 | EP2603243A2 Formulation, apparatus and method for stabilizing radiopharmaceuticals |
| 06/19/2013 | CN203001481U Multi-synthesis module for preparing radiopharmaceuticals |
| 06/19/2013 | CN1668335B Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
| 06/19/2013 | CN103167884A Stabilisation of radiopharmaceutical precursors |
| 06/19/2013 | CN103167870A Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| 06/19/2013 | CN103159842A Cys-Annexin V kit used for 99mTc labeling and preparation method and application thereof |
| 06/19/2013 | CN103159841A Method for marking Cys-Annexin V by use of 99mTc and application of method |
| 06/18/2013 | US8466261 Therapeutic using a bispecific antibody |
| 06/18/2013 | US8465726 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 06/18/2013 | US8465725 Process for production of heterodimers of glutamic acid |
| 06/18/2013 | US8465724 Vitamin receptor binding drug delivery conjugate |
| 06/18/2013 | CA2812129A1 Methods for the synthesis of 13c labeled plasmalogen |
| 06/18/2013 | CA2706111C Homogenization of a radiopharmaceutical using sonification and/or rotor-stator technology to produce a homogenous suspension, emulsion, mixture or solid suspension of immiscible ingredients |
| 06/18/2013 | CA2564895C Radium target and method for producing it |
| 06/18/2013 | CA2418144C Urocortin proteins and uses thereof |
| 06/17/2013 | WO2013009655A2 Uses of labeled hsp90 inhibitors |
| 06/17/2013 | CA2841173A1 Uses of labeled hsp90 inhibitors |
| 06/13/2013 | WO2013083024A1 Benzothiazole compound, intermediate, preparation method and use thereof |
| 06/13/2013 | WO2013082656A1 Cage amine ligands for metallo-radiopharmaceuticals |
| 06/13/2013 | WO2013082655A1 Functionalisation of cage amine ligands for metallo-radiopharmaceuticals |
| 06/13/2013 | US20130150529 Iodine-containing radial-shaped macromolecular compounds, preparation method thereof and contrast media compositions for ct comprising the some |
| 06/13/2013 | US20130149249 Imaging tuberculosis with pyrazinamide contrast agents |
| 06/13/2013 | US20130149244 Compositions, methods, and systems for the synthesis and use of imaging agents |
| 06/13/2013 | US20130149243 Method for production of f-18 labeled glutamic acid derivatives |